News

06/01/2020

Xeris Pharmaceuticals Announces Positive Results from the In-Clinic Stage of a Phase 2 Study of Its Developmental Ready-To-Use (RTU) Glucagon in Patients at Risk of Hypoglycemia During and after Aerobic Exercise


Read more

23/12/2019

Ergon acquires Palex, the leading distributor of high value-added MedTech equipment and solutions for public and private hospitals and laboratories in Iberia


Read more

20/12/2019

Big success of the First Symposium Workshop on PICC-PORT organized by Palex


Read more

19/12/2019

Snack producer Beltaste-Vanreusel acquires Dutch artisanal croquette producer Oma Bobs


Read more

12/12/2019

Protéus by Seqens launches SEQENZYM®, Enzyme Kits selected among an extensive library of Extremophile Strains for Fast Early Screening of Biocatalysts


Read more

11/12/2019

Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration


Read more

11/12/2019

Mérieux Equity Partners announces it has entered Addmedica’s capital - as a reference shareholder - in order to accelerate the company’s growth in France and abroad


Read more

10/12/2019

Xeris Pharmaceuticals Announces Positive Topline Results From the In-clinic Stage of the Phase 2 Study of Its Developmental Ready-to-use (RTU) Glucagon in Patients at Risk of Postprandial Hypoglycemia Following Bariatric Surgery


Read more

09/12/2019

EXIT: SAUSALITOS


Read more

06/12/2019

KARTESIA HAS BEEN SHORTLISTED FOR THE 2019 PRIVATE DEBT INVESTOR AWARD IN THE LOWER MID-MARKET LENDER OF THE YEAR CATEGORY


Read more

Pages